Mohamed Hassan | Medicine and Health Sciences | Best Researcher Award

Posted on 15/03/202515/03/2025 by ScienceFather

Mohamed Hassan | Medicine and Health Sciences | Best Researcher Award

Assist. Prof. Dr Mohamed Hassan, Tulane University School of Medicine, United States

Assist. Prof. Dr. Mohamed Hassan is a distinguished researcher in molecular biology, tumor biology, and virology 🧬. His groundbreaking work focuses on tumor progression, cancer stem cell biology, and innovative therapeutic strategies 🎯. With an extensive portfolio of high-impact publications 📄 and supervised doctoral candidates 🎓, his research significantly contributes to understanding melanoma resistance, non-receptor tyrosine kinases, and immune checkpoint inhibitors 🏥. He has collaborated with leading international institutions, enriching the field with novel discoveries in oncology 🔬. His contributions extend beyond research, fostering the next generation of scientists and improving clinical oncology outcomes 🏥.

Publication Profile

Orcid

Education

Dr. Mohamed Hassan earned his Ph.D. in Molecular Biology 🏅 from the University Hospital of Düsseldorf, Germany (2001), where his research focused on the interference of the Hepatitis C Virus (HCV) core protein with intracellular signal transduction in liver cells 🦠. He holds an M.Sc. in Molecular Biology 📖 from the University of Düsseldorf (1996), with a thesis on identifying and characterizing differentially expressed cDNA libraries in Plasmodium malaria chabaudi immune mice 🧪. His academic journey began with a B.Sc. in Biological Sciences 🏫 from Zagazig University, Egypt, and the University of Düsseldorf (1983). His expertise in cancer biology, virology, and molecular research 📊 has established him as a leading researcher in the field.

Experience

Assist. Prof. Dr. Mohamed Hassan is a dedicated cancer researcher with extensive expertise in tumor progression, oncological drug resistance, and precision medicine 🔬💊. He is currently a Senior Postdoctoral Fellow at the Institut National de la Santé et de la Recherche Médicale, University of Strasbourg, France (2018-2025) 🏥. Previously, he served as a Research Assistant Professor at Tulane University School of Medicine, USA (2016-2018) 🎓, and a Postdoctoral Fellow at the University Hospital of Düsseldorf, Germany (2002-2004). His groundbreaking work focuses on identifying biomarkers and developing targeted therapies to enhance cancer treatment worldwide 🌍🧬.

Research Focus

Assist. Prof. Dr. Mohamed Hassan’s research focuses on tumor progression, cancer stem-like cells, and treatment resistance 🧬. His work delves into melanoma’s resistance to standard therapies 🎯, mechanisms of tumor progression and immune evasion 🏥, and targeting cancer stem-like cells to enhance treatment efficacy 💊. He investigates the role of non-receptor tyrosine kinases in oncogenesis 🔬 and explores immune checkpoint inhibitors and their associated cutaneous adverse effects ⚕️. Additionally, his discovery of antimicrobial peptides holds promise for clinical applications 🦠. His contributions drive novel therapeutic strategies, improving cancer treatment outcomes worldwide 🌍.

Publication Top Notes

Reduction of Prostate Cancer Risk: Role of Frequent Ejaculation-Associated Mechanisms

Immune Checkpoint Inhibitor-Associated Cutaneous Adverse Events: Mechanisms of Occurrence

Non-Receptor Tyrosine Kinases: Their Structure and Mechanistic Role in Tumor Progression and Resistance

<i>hTERT</i> Epigenetics Provides New Perspectives for Diagnosis and Evidence-Based Guidance of Chemotherapy in Cancer

CD133-Dependent Activation of Phosphoinositide 3-Kinase /AKT/Mammalian Target of Rapamycin Signaling in Melanoma Progression and Drug Resistance

Mechanisms of Melanoma Progression and Treatment Resistance: Role of Cancer Stem-like Cells

Induction of Antimicrobial Protein S100A15 Expression by Oral Microbial Pathogens Is Toll-like Receptors-Dependent Activation of c-Jun-N-Terminal Kinase (JNK), p38, and NF-κB Pathways

Hsiang-Chu Pai | Medicine and Health Sciences | Best Researcher Award

Posted on 04/02/202504/02/2025 by ScienceFather

Hsiang-Chu Pai | Medicine and Health Sciences | Best Researcher Award

Prof Hsiang-Chu Pai, Chung Shan Medical University, Taiwan

Prof. Hsiang-Chu Pai, Ph.D., is a distinguished professor at the Department of Nursing, Chung Shan Medical University, Taiwan. With a background in nursing education and research, she holds a Ph.D. and MS in Nursing from Chung Shan Medical University and a BS in Nursing from Kaohsiung Medical University. Her research focuses on medical and surgical nursing care, home care, nursing education, evidence-based health care, and hospice and palliative nursing. She has received multiple honors, including the 2018 Award for Excellence in Teaching. Her publications address topics like stroke care and healthcare student communication. 🏥📚💉👩‍⚕️

Publication Profile

Scopus

Education

Prof. Hsiang-Chu Pai is an accomplished academic in the field of nursing. She holds a Ph.D. and an M.S. in Nursing from Chung Shan Medical University, Taiwan, and a B.S. in Nursing from Kaohsiung Medical University, Taiwan. With her extensive academic background, Prof. Pai has contributed significantly to nursing education and research. Her dedication to advancing the field of nursing through both teaching and research has made her a prominent figure in Taiwan’s healthcare education system. 🌟📚👩‍⚕️

Research Interests

Prof. Hsiang-Chu Pai is a distinguished expert in medical and surgical nursing care, particularly in stroke management 🧠. With a passion for home care 🏡, nursing education 📚, and evidence-based health care 🏥, she has dedicated her career to improving patient outcomes. Her work also extends to hospice and palliative nursing 🕊️, ensuring compassionate end-of-life care. Prof. Pai’s contributions have significantly shaped nursing practices, promoting the integration of research findings into everyday care. She continues to inspire healthcare professionals with her commitment to advancing nursing through education and evidence-based approaches. 💉👩‍⚕️

Honors and Awards

Prof. Hsiang-Chu Pai is a distinguished educator, recognized for her commitment to teaching excellence. In 2018, she was honored with the Award for Excellence in Teaching by Chung Shan Medical University 🎓🏆. Her dedication to nursing also earned her the prestigious B. Braun Nursing Paper Award in 2005, presented by the Taiwan Nurses Association 🏅💉. With a wealth of experience in academia and nursing, Prof. Pai continues to inspire and contribute significantly to the field of healthcare education. Her accolades reflect her passion for nurturing future professionals in the medical and nursing sectors. 👩‍⚕️📚

Research Focus

Prof. Hsiang-Chu Pai’s research focuses on improving healthcare practices and outcomes through interdisciplinary approaches. His work examines the impact of health humanities, such as the role of comics and community dialogue, on empathy and communication skills among healthcare students. Additionally, Prof. Pai explores psychological well-being, workplace resilience, and stress among healthcare workers, particularly in long-term care institutions. His studies also address the caregiving experience, including family dynamics in stroke recovery and moral distress in nursing. Overall, his research aims to enhance healthcare delivery, patient care, and professional development in nursing and related fields. 📚💉👩‍⚕️💪

Publication Top Notes

The effect of comics and Interprofessional community dialogue on health humanities, empathy, and communication among healthcare students

Effects of a nurse-led therapeutic conversations intervention in stroke patient–family caregiver dyads: A randomized control trial

Examining the Factors Affecting Psychological Well-Being in Certified Nurse Aides Working at Long-Term Care Institutions

Workplace Resilience and Stress Among Certified Nursing Assistants in Long-Term Care Institutions During the COVID-19 Pandemic

Association Between Family Functioning and Health-related Quality of Life in Stroke Survivor–Informal Family Caregiver Dyads

Effects of Professional Growth-Need Strength on Nursing Competencies: A Care-Task Design and Clinical Reasoning Program

The moral distress, protective factors, and resilience: the role of ethical decision-making competence among student nurses

Factors associated with facial pressure injury in patients receiving non-invasive positive pressure ventilation mask: A retrospective case–control study

Predictive Factors of Apathy in Stroke Survivors During the Recovery Period

Federico Bozzetti | Medicine and Health Sciences | Best Researcher Award

Posted on 06/12/202406/12/2024 by ScienceFather

Federico Bozzetti | Medicine and Health Sciences | Best Researcher Award

Dr Federico Bozzetti, ASLC, Italy

Dr. Federico Bozzetti is an esteemed Italian physician and specialist in oncology and surgery, born in Milan, Italy. He completed his studies at the University of Milan, University of Florence, and University of Pavia, followed by specialized training at renowned institutions like Lund University and Columbia University. With over 710 publications, including articles on cancer nutrition and home parenteral nutrition, Dr. Bozzetti is a leader in gastrointestinal oncology and artificial nutrition. He has held significant roles in prestigious societies, including as President of ESPEN. His research focuses on cancer treatment, liver transplantation, and cancer-related malnutrition.

Publication Profile

Orcid

Educational Background

Dr. Federico Bozzetti is a distinguished medical professional with multiple specializations in medicine, surgery, oncology, and epidemiology, earned from prestigious institutions such as the University of Milan, University of Pavia, and University of Florence 🎓🏥. Known for his academic excellence, he graduated with cum laude honors and achieved top scores in various examinations 🌟📚. Dr. Bozzetti’s vast expertise in medicine and cancer care has significantly impacted the field, reflecting his dedication to both clinical practice and research 🔬💉. His contributions continue to shape advancements in healthcare, particularly in oncology and epidemiology 🌍💪.

Experience

Dr. Federico Bozzetti is a renowned expert in cancer treatment and nutritional support. He has held leadership roles at prestigious institutions, including the Istituto Nazionale per lo Studio e la Cura dei Tumori in Milan. His groundbreaking research and clinical contributions have greatly advanced cancer care, particularly in the areas of nutrition for cancer patients. With a deep commitment to improving patient outcomes, Dr. Bozzetti’s work continues to inspire and shape the future of oncology and supportive care.

Global Influence

Dr. Bozzetti is a highly influential figure in the field of parenteral and enteral nutrition. His active involvement in numerous professional societies showcases his global impact. He is a founder and key member of both the European and Italian Societies of Parenteral and Enteral Nutrition (ESPEN and ISPEN). In addition to his contributions to these societies, Dr. Bozzetti plays a significant role in international collaborations, further advancing the field. He is also an esteemed member of various editorial boards, enhancing the scientific community with his expertise. 🌍🍽️📚💡🌱

Research Focus

Dr. Federico Bozzetti’s research primarily focuses on clinical nutrition, particularly in the context of cancer patients and those requiring specialized nutrition support. His work explores the role of physical exercise in improving outcomes for advanced cancer patients undergoing systemic therapy, as well as the challenges and outcomes of home enteral nutrition for patients and caregivers. Dr. Bozzetti also revisits the importance of nutrition for malnourished cancer patients, and he contributes to guidelines on home parenteral nutrition. His research seeks to improve patient care through better understanding of nutritional needs and therapy during illness. 🍽️🏥💪📚

Publication top Notes

Potential Benefits from Physical Exercise in Advanced Cancer Patients Undergoing Systemic Therapy? A Narrative Review of the Randomized Clinical Trials

Patients’ and caregivers’ perspective on challenges and outcomes with tube feeding: Analysis of home enteral nutrition survey data

The role of the nutrition in malnourished cancer patients: Revisiting an old dilemma

ESPEN practical guideline: Home parenteral nutrition

How to deal with micronutrient product shortage – Editorial

Cost of HPN in incurable cancer patients: Author’s response re. “SINPE Position Paper on the use of home parenteral nutrition in cancer patients”

A multi-national survey of experience and attitudes towards commencing home parenteral nutrition for patients with advanced cancer

Does nutrition support during chemotherapy increase long-term survival of cancer patients? Lessons from the past and future perspectives

TEMPORARY REMOVAL: SINPE Position Paper on the use of home parenteral nutrition in cancer patients

Emmanouil Dermitzakis | Medicine and Health Sciences | Best Researcher Award

Posted on 16/09/202416/09/2024 by ScienceFather

Emmanouil Dermitzakis | Medicine and Health Sciences | Best Researcher Award

Dr Emmanouil Dermitzakis, Euromedica General Clinic, Greece

Dr. Emmanouil Dermitzakis appears to be a strong candidate for the Best Researcher Award based on the following criteria:

Publication profile

google scholar

Qualifications & Experience

Extensive Training and Certification: Dr. Dermitzakis has undergone comprehensive training in Internal Medicine, Psychiatry, and Neurology, with board certification in Neurology.

Diverse Clinical Experience: He has worked in various roles, including as a research fellow, neurologist in multiple settings, and medical advisor. His roles have spanned private practice, academic institutions, and specialized clinics.

Research Contributions

Clinical Trials & Studies: Dr. Dermitzakis has been involved as both a Sub-Investigator and Principal Investigator in numerous significant clinical trials, such as the ECASS 3 trial and various migraine-related studies. His research includes evaluating new treatments and methodologies for migraine and headache disorders.

Published Works: He has published numerous articles in reputable journals, covering a wide range of topics from headache management to the effects of chemotherapy on the autonomic nervous system. His work includes research on migraine treatments, including botulinum toxin and novel therapies.

Editorial and Advisory Roles

Guest Editor: He has served as a Guest Editor for a special issue on headache disorders, reflecting his expertise and leadership in the field.

Medical Advisory Roles: As a medical advisor for the Hellenic Society of Migraine and Headache Patients, Dr. Dermitzakis contributes to advancing treatment strategies and improving patient care.

Notable Publications

His research includes impactful studies such as the evaluation of onabotulinumtoxinA in chronic migraine treatment, and the effects of chemotherapy on the autonomic nervous system. These contributions have been published in high-impact journals like The Journal of Headache and Pain and BMC Neurology.

Conclusion

Dr. Dermitzakis’s combination of clinical expertise, substantial research experience, leadership in neurology and headache management, and influential publications make him a notable candidate for the Best Researcher Award. His ongoing contributions to neurology and headache research demonstrate a commitment to advancing medical knowledge and improving patient outcomes.

Publication top notes

Patients’ preferences for headache acute and preventive treatment

Clinical experience with transcutaneous supraorbital nerve stimulation in patients with refractory migraine or with migraine and intolerance to topiramate: a prospective …

Sustained onabotulinumtoxinA therapeutic benefits in patients with chronic migraine over 3 years of treatment

Onabotulinumtoxin-A treatment in Greek patients with chronic migraine

The impact of paclitaxel and carboplatin chemotherapy on the autonomous nervous system of patients with ovarian cancer

Headache patients in the emergency department of a Greek tertiary care hospital

OnabotulinumtoxinA add-on to monoclonal anti-CGRP antibodies in treatment-refractory chronic migraine

Open label prospective experience of supplementation with a fixed combination of magnesium, vitamin B2, feverfew, andrographis paniculata and coenzyme Q10 for episodic migraine …

Long‐term adherence, safety, and efficacy of repeated onabotulinumtoxinA over five years in chronic migraine prophylaxis

Efficacy and safety of fremanezumab for migraine prophylaxis in patients with at least three previous preventive failures: prospective, multicenter, real‐world data from a …

Ahmed Ali | Medicine and Health Sciences | Best Researcher Award

Posted on 31/07/202431/07/2024 by ScienceFather

Ahmed Ali | Medicine and Health Sciences | Best Researcher Award

Dr Ahmed Ali, Beni-Suef University, Egypt

Based on Dr. Ahmed Ali’s extensive background in veterinary medicine, his significant contributions to vaccine development, and his active research in poultry diseases and vaccine efficacy, he appears to be a strong candidate for the Research for Best Researcher Award.

Publication profile

google scholar

Education and Training

Dr. Ali holds advanced degrees in Veterinary Medicine and Poultry Diseases from Beni-Suef University and The Ohio State University, showcasing a solid educational foundation in his field.

Research Contributions

His work includes leading the development of reverse genetics vaccines for avian influenza and Newcastle disease, and his involvement in live attenuated and inactivated vaccine research. This demonstrates a high level of expertise and impact in vaccine research and development.

Professional Experience

Dr. Ali has held various positions, from demonstrator to technical manager, and has been involved in significant roles related to vaccine R&D and quality control at MEVAC and the National Veterinary Vaccine Co. His roles highlight a career dedicated to advancing vaccine technologies and ensuring their quality and safety.

Publications

He has authored numerous research articles on vaccine safety, efficacy, and development, contributing valuable knowledge to the field. His research is published in reputable journals, reflecting the quality and relevance of his work.

Certifications and Skills

Dr. Ali’s certifications in biorisk management, strategic planning, and Six Sigma further demonstrate his commitment to excellence and continuous improvement in his field.

Field Achievements

His leadership in developing innovative vaccines and ensuring compliance with international standards underscores his significant contributions to veterinary science.